Ethical Aspects of Using CRISPR-Cas9 in Medicine in Kazakhstan and Worldwide

CRISPR-Cas9 is a new emerging genome editing tool, that gives hope as a cure to various diseases, including cancer and hereditary diseases. Although its accuracy in editing DNA is fascinating, recent breakthroughs in this field raise crucial ethical and legal issues. Usage of CRISPR-Cas9 raises concerns pertaining to safety, availability, religious and societal impact. Nowadays, some of the high-income countries have developed regulatory frameworks to address these concerns, however there is still a lack of global concrete regulations for all nations. In Kazakhstan, even though genome editing technology is used mostly in research, we are in demand of developing bioethical principles based on international practices. The regulatory framework would ensure a responsible approach in using this tool in medicine and research. In this review, we explored international ethical practices and examined the current situation in Kazakhstan in implementing genome editing technology. CRISPR-Cas9 is a new emerging genome editing tool, that gives hope as a cure to various diseases, including cancer and hereditary diseases. Although its accuracy in editing DNA is fascinating, recent breakthroughs in this field raise crucial ethical and legal issues. Usage of CRISPR-Cas9 raises concerns pertaining to safety, availability, religious and societal impact. Nowadays, some of the high-income countries have developed regulatory frameworks to address these concerns, however there is still a lack of global concrete regulations for all nations. In Kazakhstan, even though genome editing technology is used mostly in research, we are in demand of developing bioethical principles based on international practices. The regulatory framework would ensure a responsible approach in using this tool in medicine and research. In this review, we explored international ethical practices and examined the current situation in Kazakhstan in implementing genome editing technology.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Medicine of Kazakhstan
Published
2026-01-15
DOI
https://doi.org/10.23950/jcmk/17746
Primary Topic
CRISPR and Genetic Engineering
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Ethical Aspects of Using CRISPR-Cas9 in Medicine in Kazakhstan and Worldwide

Askhat Myngbay, Arinaz Kabyl
Journal of Clinical Medicine of Kazakhstan
CRISPR and Genetic Engineering
article

Ethical Aspects of Using CRISPR-Cas9 in Medicine in Kazakhstan and Worldwide

Askhat Myngbay, Arinaz Kabyl
article en

Abstract

CRISPR-Cas9 is a new emerging genome editing tool, that gives hope as a cure to various diseases, including cancer and hereditary diseases. Although its accuracy in editing DNA is fascinating, recent breakthroughs in this field raise crucial ethical and legal issues. Usage of CRISPR-Cas9 raises concerns pertaining to safety, availability, religious and societal impact. Nowadays, some of the high-income countries have developed regulatory frameworks to address these concerns, however there is still a lack of global concrete regulations for all nations. In Kazakhstan, even though genome editing technology is used mostly in research, we are in demand of developing bioethical principles based on international practices. The regulatory framework would ensure a responsible approach in using this tool in medicine and research. In this review, we explored international ethical practices and examined the current situation in Kazakhstan in implementing genome editing technology. CRISPR-Cas9 is a new emerging genome editing tool, that gives hope as a cure to various diseases, including cancer and hereditary diseases. Although its accuracy in editing DNA is fascinating, recent breakthroughs in this field raise crucial ethical and legal issues. Usage of CRISPR-Cas9 raises concerns pertaining to safety, availability, religious and societal impact. Nowadays, some of the high-income countries have developed regulatory frameworks to address these concerns, however there is still a lack of global concrete regulations for all nations. In Kazakhstan, even though genome editing technology is used mostly in research, we are in demand of developing bioethical principles based on international practices. The regulatory framework would ensure a responsible approach in using this tool in medicine and research. In this review, we explored international ethical practices and examined the current situation in Kazakhstan in implementing genome editing technology.

Journal of Clinical Medicine of KazakhstanVol. 23(1)
Aktobe Regional State University named after K.Zhubanov (KZ)
Partnerships for the goals
Openalex Percentile: Top 43%
CRISPR and Genetic Engineering
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.